With Tivoli’s True RGB+W technology, the ADAPT system delivers more than 16 million combinations of pure and precise color tones.

The ADAPT study also showed that those that transitioned to the MiniMed 780G system experienced a significant increase in treatment satisfaction 2 and reduction in fear of hypoglycemia 3.

Adaptive Biotechnologies Corporation ('Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company ...

The ADAPT study will evaluate the safety and effectiveness of the Calibreye surgical system in up to 70 patients with ...